TERAMO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.730
EU - Europa 963
AS - Asia 430
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 4.127
Nazione #
US - Stati Uniti d'America 2.723
IT - Italia 616
CN - Cina 265
SG - Singapore 136
DE - Germania 87
GB - Regno Unito 65
FI - Finlandia 57
SE - Svezia 54
FR - Francia 26
UA - Ucraina 16
NL - Olanda 14
VN - Vietnam 14
IN - India 9
RU - Federazione Russa 8
CA - Canada 7
CH - Svizzera 5
IE - Irlanda 5
PL - Polonia 4
HK - Hong Kong 3
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
MK - Macedonia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 4.127
Città #
Fairfield 400
Chandler 287
Woodbridge 264
Ann Arbor 230
Ashburn 229
Houston 159
Cambridge 149
Wilmington 136
Seattle 129
Singapore 114
Jacksonville 94
Padova 89
Boardman 70
Santa Clara 64
Beijing 63
Milan 45
Princeton 45
San Diego 40
Guangzhou 32
Helsinki 32
Medford 31
Des Moines 26
Nanjing 23
Rome 16
Roxbury 16
Dong Ket 14
Hebei 10
Montecatini Terme 10
Venice 10
Changsha 9
London 9
Mestre 9
Bologna 8
Jinan 8
Cadoneghe 7
Cagliari 7
Nanchang 7
Frankfurt am Main 6
Naples 6
New York 6
Pune 6
Verona 6
Dublin 5
Florence 5
Norwalk 5
Seriate 5
Shenyang 5
Castegnero 4
Castelfranco di Sotto 4
Cernusco sul Naviglio 4
Cuneo 4
Falls Church 4
Hefei 4
Mestrino 4
Ningbo 4
Phoenix 4
Portland 4
Prescot 4
Sant'Elena 4
Shanghai 4
Zhengzhou 4
Bolzano 3
Bournemouth 3
Dallas 3
Dossobuono 3
Hong Kong 3
Lappeenranta 3
Lavagno 3
Los Angeles 3
Montebelluna 3
Munich 3
Ogden 3
Palermo 3
Pisa 3
Redwood City 3
Washington 3
Alba 2
Albignasego 2
Auburn Hills 2
Baotou 2
Bassano del Grappa 2
Battaglia Terme 2
Bergamo 2
Boccasette 2
Borås 2
Casier 2
Cento 2
Chengdu 2
Chiampo 2
Chioggia 2
Chongqing 2
Cittanova 2
Civitanova Marche 2
Cogliate 2
Creazzo 2
Domusnovas Canales 2
Edinburgh 2
Falkenstein 2
Felino 2
Freiburg im Breisgau 2
Totale 3.095
Nome #
Meccanismi patogenetici della malattia linfoproliferativa dei linfociti granulati 376
Identification of a miR-146b-FasL axis in the development of neutropenia in T large granular lymphocyte leukemia 271
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation 174
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 161
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction? 157
Sarcoidosis is a Th1/Th17 multisystem disorder 136
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 136
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 118
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study 113
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30 111
TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis 111
T cell large granular lymphocyte leukemia and chronic NK lymphocytosis 108
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 107
A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia 107
CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. 103
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients 101
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 98
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells 97
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 95
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes 94
Analysis of KIR framework loci in patients with NK-type lymphoproliferative disease of granular lymphocytes (LDGL) 94
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis 90
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia 87
Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone? 85
Cell-mediated autoimmune mechanisms involved in the pathogenesis of primary aldosteronism. 80
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients 80
KIR/HLA-I mismatching and risk of relapse in paediatric patients undergoing non-haploidentical allogeneic haematopoietic stem cell transplantation 77
KIR/HLA class I mismatching and risk of relapse in pediatric patients undergoing allogeneic bone marrow transplantation 74
Synovial colony-stimulating factor-1m RNA expression in diffuse pigmented villonodular synovitis 73
Analysis of KIR framework loci in patients with NK-type lymphoproliferative disease of granular lymphocytes (LDGL) 70
Hematopoietic lineage cell specific protein 1 (HS1) is a new prognostic marker and is involved in cell growth of B-cell chronic lymphocytic leukemia 66
KIR/HLA-I Mismatching Predicts Risk of Relapse in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. 65
Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases? 58
Large granular lymphocyte leukemia 51
KIR/HLA class I mismatching and risk of relapse in pediatric patients undergoing allogeneic bone marrow transplantation 46
Studio dell’espressione genica del colony-stimulating factor-1 nella sinovite villo nodulare pigmentosa diffusa 40
Neutropenia and large granular lymphocyte leukemia: From pathogenesis to therapeutic options 39
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 36
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience 33
All that glitters is not LGL Leukemia 32
Not all LGL leukemias are created equal 28
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 28
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients 23
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 13
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia 12
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders 10
T-cell clones of uncertain significance. When is the rogue clone dangerous? 6
Proteasome Inhibitors Induce Apoptosis in Ex Vivo Cells of T-Cell Prolymphocytic Leukemia 3
Totale 4.173
Categoria #
all - tutte 17.467
article - articoli 15.713
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 348
Totale 33.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020433 0 0 0 0 0 0 69 83 74 84 84 39
2020/2021555 49 42 40 27 20 21 24 60 80 59 55 78
2021/2022624 42 53 57 40 20 51 33 52 38 38 67 133
2022/2023595 97 83 22 63 83 62 14 38 71 11 38 13
2023/2024616 15 29 47 48 60 68 55 43 19 41 47 144
2024/2025501 21 90 64 82 148 92 4 0 0 0 0 0
Totale 4.173